We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Cullen G. Taylor

Northern Virginia

Cullen G. Taylor
Practice Group
Intellectual Property

Cullen Taylor helps companies structure and negotiate their most complex commercial transactions, particularly those involving the development, acquisition, and commercialization of intellectual property and technology. Cullen takes a practical, results-oriented approach to getting deals done, drawing on his broad experience across multiple industries to anticipate and address problems before they arise.

Trained as an intellectual property lawyer, Cullen understands the technical and business issues that arise as parties enter, live under, and exit long-term commercial arrangements. Cullen is skilled at structuring and drafting contracts that address these concerns while keeping the client's business goals at front and center.

Given his versatility, Cullen practices across a variety of industries, including life sciences, communications, sports, information technology, and media. In the life sciences industries, Cullen handles a variety of transactions, including product acquisition, licensing, development, collaboration, manufacture, supply, and co-promotion agreements. In the cable and communications fields, Cullen advises clients in connection with network, transport, interconnection, cell tower backhaul, hosting, co-location, and other communications service agreements.

Cullen is Co-Head (Americas) of the firm's Life Sciences Transactions team. He regularly collaborates with his colleagues in the firm's Corporate practice to address intellectual property and technology-related issues that arise in mergers, acquisitions, and other corporate transactions.

Representative experience

Representing Incyte Corporation in its license and collaboration agreement with MacroGenics relating to an anti-PD-1 antibody.

Representing multiple pharmaceutical companies and diagnostics manufacturers in collaboration agreements to develop companion diagnostics for drug products.

Representing Regeneron in a genomics collaboration with Geisinger Health Systems.

Representing Helsinn Healthcare in connection with license and collaboration agreements with MEI Pharma and Taiho Pharmaceuticals.

Representing Helsinn Therapeutics in its co-promotion agreement with Novartis relating to Zykadia.

Representing Cormedix in various license, collaboration, supply, and distribution agreements relating to its Neutrolin product.

Representing Daiichi Sankyo in its co-commercialization agreement with AstraZeneca relating to MOVANTIK in the United States.

Representing Naver on the acquisition of Xerox Research Centre Europe.

Representing Novartis in the sale of its animal health business to Eli Lilly for approximately US$5.4bn.

Ongoing representation of Charter Communications in connection with a variety of commercial agreements.

Ongoing representation of the College Football Playoff in connection with various commercial agreements.

Education and admissions


  • J.D., Harvard Law School, 2000
  • B.A., with distinction, Phi Beta Kappa, University of Virginia, 1997


  • Member, American Bar Association
  • Member, Intellectual Property Owners Association
  • Member, Raven Society
  • Member, Virginia Bar Association

Bar admissions and qualifications

  • Virginia


BTI Client Service All-Star

BTI Consulting Group


Rising Star, 2008, 2010, 2015

Virginia Super Lawyers


Rising Star

Washington, D.C. Super Lawyers


Intellectual Property

Virginia Legal Elite


Young Lawyer

Virginia Legal Elite


Health Law

Virginia Legal Elite

Latest thinking and events

Loading data